Stonepine Capital Management, LLC

13F Holdings History for Aprea Therapeutics, Inc. - Common Stock (APRE)

Symbol: APRE on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 239K shares
Security Ownership: 4.3%

Shares, Excluding Options vs Price

Value, Excluding Options

Stonepine Capital Management, LLC ownership in Aprea Therapeutics, Inc. Common Stock (APRE)

2025-05-14 - Stonepine Capital Management, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 239K shares of Aprea Therapeutics, Inc. Common Stock (APRE). This represents 4.3% percent ownership of the company. In their previous filing dated 2025-02-13, Stonepine Capital Management, LLC had reported owning 286K shares, indicating a decrease of -16.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Stonepine Capital Management, LLC	4.3%	-16%	$488K	239K	-46,979	-16.4%	$2.04	13G/A	3/31/2025	14 May 2025 16:04:41
Stonepine Capital Management, LLC	5.1%		$584K	286K			$2.04	13G/A	12/31/2024	13 Feb 2025 12:15:12

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
3/31/2025			$14.4K	102K			$0.14^*	Q1 2025
12/31/2024	0.4%	+0.03%	$491K	149K	+12,047	+8.78%	$3.29	Q4 2024
9/30/2024	0.24%		$377K	137K			$2.75	Q3 2024
6/30/2024	0.51%	+0.51%	$558K	137K	+137,174	NEW	$4.07	Q2 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.